Benitec Biopharma Inc. (BNTC)
NASDAQ: BNTC · Real-Time Price · USD
14.10
+0.32 (2.32%)
At close: Oct 8, 2025, 4:00 PM EDT
14.10
0.00 (0.00%)
After-hours: Oct 8, 2025, 4:04 PM EDT
Benitec Biopharma Market Cap
Benitec Biopharma has a market cap or net worth of $370.13 million as of October 8, 2025. Its market cap has increased by 294.59% in one year.
Market Cap
370.13M
Enterprise Value
271.40M
1-Year Change
294.59%
Ranking
Category
Stock Price
$14.10
Market Cap Chart
Since June 26, 2014, Benitec Biopharma's market cap has decreased from $2.23B to $370.13M, a decrease of -83.38%. That is a compound annual growth rate of -14.69%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Oct 7, 2025 | 361.73M | 23.36% |
Dec 31, 2024 | 293.22M | 3,429.00% |
Dec 29, 2023 | 8.31M | 74.68% |
Dec 30, 2022 | 4.76M | -77.78% |
Dec 31, 2021 | 21.41M | 61.99% |
Dec 31, 2020 | 13.22M | -90.51% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 753.98B |
Johnson & Johnson | 454.31B |
AbbVie | 413.22B |
UnitedHealth Group | 326.22B |
Novo Nordisk | 264.73B |
AstraZeneca | 264.35B |
Novartis AG | 256.18B |
Abbott Laboratories | 234.25B |